Limited sampling strategies for therapeutic drug monitoring of mycophenolate mofetil therapy in patients with autoimmune disease.

MLA

de Winter, Brenda C. M., et al. “Limited Sampling Strategies for Therapeutic Drug Monitoring of Mycophenolate Mofetil Therapy in Patients with Autoimmune Disease.” Therapeutic Drug Monitoring, vol. 31, no. 3, June 2009, pp. 382–90. EBSCOhost, https://doi.org/10.1097/FTD.0b013e3181a23f1a.

APA

de Winter, B. C. M., Neumann, I., van Hest, R. M., van Gelder, T., & Mathot, R. A. A. (2009). Limited sampling strategies for therapeutic drug monitoring of mycophenolate mofetil therapy in patients with autoimmune disease. Therapeutic Drug Monitoring, 31(3), 382–390. https://doi.org/10.1097/FTD.0b013e3181a23f1a

Chicago

de Winter, Brenda C M, Irmgard Neumann, Reinier M van Hest, Teun van Gelder, and Ron A A Mathot. 2009. “Limited Sampling Strategies for Therapeutic Drug Monitoring of Mycophenolate Mofetil Therapy in Patients with Autoimmune Disease.” Therapeutic Drug Monitoring 31 (3): 382–90. doi:10.1097/FTD.0b013e3181a23f1a.